98%
921
2 minutes
20
Objective: This study assessed and compared health-related quality of life (HRQoL) in patients with oropharyngeal cancer in Korea using the following instruments: the EuroQol 5-Dimensions 5-Level (EQ-5D-5L); EORTC Quality of Life Questionnaire - Core 30 (QLQ-C30); and the EORTC Quality of Life Questionnaire - Head and Neck 35 (QLQ-H&N35). The principal goal was to evaluate suitability of the EQ-5D-5L for assessing HRQoL in patients with oropharyngeal cancer.
Methods: A survey was conducted from August 2023 to March 2024 in 297 patients with oropharyngeal cancer across 14 hospitals in Korea. HRQoL data were collected using the EQ-5D-5L, QLQ-C30, and QLQ-H&N35 instruments. Descriptive statistical analyses were performed based on sociodemographic characteristics and correlation analyses between the instruments. A multiple regression analysis was also conducted to identify significant EORTC domains influencing the EQ-5D-5L index.
Results: All EQ-5D-5L items correlated significantly with the QLQ-C30 items but not with the QLQ-H&N35 items. Moderate or strong correlations were observed in 37 % of QLQ-C30 and EQ-5D-5L domain comparisons, while 18 % of QLQ-H&N35 and EQ-5D-5L domain comparisons showed moderate correlations. However, multiple regression analysis revealed that the QLQ-C30 and QLQ-H&N35 scales explained 66.3 % of the EQ-5D-5L index variance, indicating a substantial relationship between these instruments.
Conclusions: The EORTC domains meaningfully explain the EQ-5D-5L index. These findings support using the EQ-5D-5L to calculate quality-adjusted life years for patients with oropharyngeal cancer and facilitate economic evaluations that inform clinical practice and policymaking.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.oraloncology.2025.107342 | DOI Listing |
Int J Radiat Oncol Biol Phys
September 2025
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Department of Health Services Research, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Nursing, Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne, Melbourne,
Purpose: This study examined head and neck cancer treatment outcome priorities in patients with human papillomavirus-associated oropharyngeal cancer (HPVOPC) before and 12 months (12m) after (chemo)radiotherapy ([C]RT).
Methods And Materials: Eligible patients were diagnosed with HPVOPC suitable for curative-intent primary [C]RT. Study data included responses to a modified version of the Chicago Priorities Scale (CPS-modified) and select items from the MDASI Head and Neck Cancer Module (MDASI-HN).
Infect Drug Resist
August 2025
Department of Clinical Laboratory, Sanmen People's Hospital, Sanmen, Zhejiang, People's Republic of China.
is usually a commensal of the oropharynx but can occasionally cause invasive disease. Herein, we report a rare case of bacteremia in a female with a 7-year history of aortic valve replacement (AVR), who presented with persistent fever but no respiratory symptoms or valvular vegetations. Blood cultures yielded , identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and confirmed via 16S rRNA sequencing.
View Article and Find Full Text PDFLancet Oncol
September 2025
Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Background: Standard adjuvant chemoradiotherapy (60-66 Gy) following surgery for HPV-associated oropharyngeal squamous cell carcinoma has excellent oncological control but high treatment morbidity. We aimed to compare toxicity of a 30-36 Gy regimen of de-escalated adjuvant radiotherapy and standard of care treatment.
Methods: We did this phase 3, open-label, randomised controlled trial in two academic sites in the USA.
Ticks Tick Borne Dis
September 2025
Service de Maladies Infectieuses et Tropicales Hôpital Civils de Colmar, 39 avenue de la liberté 68024 Colmar, France; Service de Maladies Infectieuses et Tropicales Hôpitaux universitaires de Strasbourg, Nouvel Hôpital Civil quai Louis Pasteur, 67000 Strasbourg France; Université de Strasbourg
Tularemia is a bacterial zoonosis endemic to the Northern Hemisphere, transmitted through various modes and presenting with diverse clinical manifestations. In recent years, the number of notifications (tularemia is a reportable disease in France) have increased and the spectrum of clinical forms have changed. We conducted a retrospective study of tularemia incidence diagnosed in 2024 at two major hospitals in Alsace, a small region of Northeastern France.
View Article and Find Full Text PDFLaryngoscope
September 2025
Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.